US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
DE69419523T2
(de)
*
|
1993-11-22 |
1999-11-25 |
Upjohn Co |
Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
CN1046520C
(zh)
*
|
1994-11-15 |
1999-11-17 |
法玛西雅厄普约翰美国公司 |
二环噁嗪及噻嗪噁唑烷酮抗菌剂
|
NZ302844A
(en)
*
|
1995-02-03 |
1999-06-29 |
Upjohn Co |
Antimicrobial hetero-aromatic ring substituted phenyloxazolidinones
|
CA2218088A1
(en)
*
|
1995-05-11 |
1996-11-14 |
Pharmacia & Upjohn Company |
Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
|
CN1072222C
(zh)
*
|
1995-09-01 |
2001-10-03 |
法玛西雅厄普约翰公司 |
以c-c键连接于4-8元杂环环的苯基噁唑烷酮
|
MX9703040A
(es)
*
|
1995-09-12 |
1997-07-31 |
Upjohn Co |
Antimicrobianos de feniloxazolidinona.
|
ES2214546T3
(es)
*
|
1995-09-15 |
2004-09-16 |
PHARMACIA & UPJOHN COMPANY |
N-oxidos de aminoariloxazolidinona.
|
ZA968661B
(en)
*
|
1995-11-17 |
1998-04-14 |
Upjohn Co |
Oxazolidinone antibacterial agent with tricyclic substituents.
|
ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
RU2176643C2
(ru)
*
|
1996-04-11 |
2001-12-10 |
Фармация Энд Апджон Компани |
Способ получения 5-гидроксиметил замещенных оксазолидинонов, способ получения 5-аминометил замещенных оксазолидиноновых аминов, оксазолидинонсульфонат
|
AT403803B
(de)
|
1996-04-19 |
1998-05-25 |
Sanochemia Ltd |
Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
|
GB9609919D0
(en)
*
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9614238D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
GB9614236D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
KR100307211B1
(ko)
*
|
1997-05-24 |
2001-11-30 |
손 경 식 |
옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
|
US6037354A
(en)
|
1997-06-18 |
2000-03-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
WO1999002525A1
(en)
*
|
1997-07-11 |
1999-01-21 |
Pharmacia & Upjohn Company |
Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
KR100467309B1
(ko)
*
|
1997-09-04 |
2005-07-18 |
씨제이 주식회사 |
옥사졸리디논유도체및그의제조방법및항균제조성물
|
KR100463111B1
(ko)
*
|
1997-10-30 |
2005-06-13 |
씨제이 주식회사 |
신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
|
RU2205822C2
(ru)
|
1997-11-07 |
2003-06-10 |
Фармация Энд Апджон Компани |
Способы получения (s)-оксазолидинонов, (s)-вторичный спирт, соединение, способ получения спирта
|
HUP0100470A3
(en)
*
|
1997-11-12 |
2002-08-28 |
Upjohn Co |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
US6040306A
(en)
*
|
1997-11-18 |
2000-03-21 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
CN1546030A
(zh)
*
|
1997-11-18 |
2004-11-17 |
�������Ŷ���Լ��������˾ |
噁唑烷酮衍生物在治疗关节炎和减少癌症化学疗法毒性中的应用
|
AU780197B2
(en)
*
|
1997-11-18 |
2005-03-10 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
DE69830811T2
(de)
*
|
1997-11-18 |
2006-04-27 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Verwendung von Oxazolidinonderivaten zur Behandlung von Psoriasis
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6239152B1
(en)
|
1998-01-23 |
2001-05-29 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
AU757197B2
(en)
*
|
1998-02-13 |
2003-02-06 |
Pharmacia & Upjohn Company |
Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
|
GB9812019D0
(en)
*
|
1998-06-05 |
1998-07-29 |
Zeneca Ltd |
Chemical compounds
|
CA2333332A1
(en)
|
1998-06-05 |
1999-12-16 |
Astrazeneca Ab |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
CN1129581C
(zh)
*
|
1998-09-22 |
2003-12-03 |
山之内制药株式会社 |
氰基苯基衍生物
|
AU764980B2
(en)
*
|
1998-11-27 |
2003-09-04 |
Pharmacia & Upjohn Company |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
AU4224699A
(en)
|
1999-01-27 |
2000-08-18 |
Pharmacia & Upjohn Company |
Assays for modulators of elongation factor p activity
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
MXPA02000985A
(es)
*
|
1999-07-28 |
2002-07-30 |
Upjohn Co |
Oxazolidinonas y su uso como antiinfecciosos.
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
AR027261A1
(es)
*
|
2000-02-02 |
2003-03-19 |
Upjohn Co |
Linezolid forma cristalina ii
|
US6642238B2
(en)
|
2000-02-10 |
2003-11-04 |
Pharmacia And Upjohn Company |
Oxazolidinone thioamides with piperazine amide substituents
|
US6514529B2
(en)
*
|
2000-03-22 |
2003-02-04 |
Pharmacia & Upjohn Company |
Oxazolidinone tablet formulation
|
MY127336A
(en)
|
2000-03-22 |
2006-11-30 |
Upjohn Co |
Container for linezolid iv solution
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
JP2003535860A
(ja)
|
2000-06-05 |
2003-12-02 |
ドン・ア・ファーム・カンパニー・リミテッド |
新規なオキサゾリジノン誘導体及びその製造方法
|
JP2004501965A
(ja)
|
2000-06-30 |
2004-01-22 |
ファルマシア・アンド・アップジョン・カンパニー |
細菌感染を治療するための組成物および方法
|
HUP0302918A2
(hu)
*
|
2000-07-17 |
2003-12-29 |
Ranbaxy Laboratories Limited |
Mikrobaellenes oxazolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
|
WO2003008389A1
(en)
*
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
WO2002032857A1
(en)
|
2000-10-17 |
2002-04-25 |
Pharmacia & Upjohn Company |
Methods of producing oxazolidinone compounds
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
ES2186550B2
(es)
*
|
2001-06-27 |
2003-11-16 |
Vita Lab |
Nuevos derivados de oxazolidinonas como antibacterianos.
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
MXPA04002303A
(es)
*
|
2001-09-11 |
2004-06-29 |
Astrazeneca Ab |
Oxazolidinona y/o isoxazolina como agentes antibacterianos.
|
US20050043374A1
(en)
*
|
2001-10-25 |
2005-02-24 |
Gravestock Michael Barry |
Aryl substituted oxazolidinones with antibacterial activity
|
WO2003035073A1
(en)
|
2001-10-25 |
2003-05-01 |
Astrazeneca Ab |
Isoxazoline derivatives useful as antimicrobials
|
TW200302095A
(en)
*
|
2002-01-25 |
2003-08-01 |
Upjohn Co |
Oxazolidinone cotherapy
|
WO2003066631A1
(en)
*
|
2002-02-05 |
2003-08-14 |
Pharmacia & Upjohn Company |
Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
|
AR038536A1
(es)
*
|
2002-02-25 |
2005-01-19 |
Upjohn Co |
N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
|
US7141588B2
(en)
*
|
2002-02-25 |
2006-11-28 |
Pfizer, Inc. |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
IL164195A0
(en)
*
|
2002-03-29 |
2005-12-18 |
Upjohn Co |
Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
|
US20060229316A1
(en)
*
|
2002-04-01 |
2006-10-12 |
Lohray Braj B |
Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
|
WO2003097059A1
(en)
*
|
2002-05-15 |
2003-11-27 |
Ranbaxy Laboratories Limited |
Polymorphic forms of phenyl oxazolidinone derivatives
|
EA200500283A1
(ru)
*
|
2002-07-29 |
2005-08-25 |
Рэнбакси Лабораториз Лимитед |
Производные оксазолидинона как противомикробные средства
|
AU2003259159A1
(en)
*
|
2002-08-12 |
2004-02-25 |
Pharmacia & Upjohn Company Llc |
N-aryl-2-oxazolidinones and their derivatives
|
US20070167414A1
(en)
*
|
2002-08-22 |
2007-07-19 |
Orchid Chemicals & Pharmaceuticals Limited |
Novel antibacterial agents
|
US7217726B2
(en)
*
|
2002-08-22 |
2007-05-15 |
Orchid Chemicals & Pharmaceuticals Limited |
Antibacterial agents
|
WO2004026848A1
(en)
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
US6875784B2
(en)
|
2002-10-09 |
2005-04-05 |
Pharmacia & Upjohn Company |
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
|
JP2006504726A
(ja)
*
|
2002-10-10 |
2006-02-09 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
抗菌性1−アリールジヒドロピリドン化合物
|
DE60309504T2
(de)
*
|
2002-11-21 |
2007-05-16 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5-carbosäureamid-derivate und verwandte verbindungen als antibakterielle mittel
|
AU2002357561A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Nanjing Chang'ao Pharmaceutical Science And Technology Limited Company |
Oxazolidine derivative, methods of preparation and uses
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
BRPI0407304A
(pt)
*
|
2003-02-07 |
2006-01-10 |
Warner Lambert Co |
Agentes antibacterianos
|
MXPA05007724A
(es)
*
|
2003-02-07 |
2005-09-30 |
Warner Lambert Co |
Agentes antibacterianos.
|
US20040204463A1
(en)
*
|
2003-04-01 |
2004-10-14 |
Harris Christina Renee |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
WO2004089944A1
(en)
*
|
2003-04-07 |
2004-10-21 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
WO2004113329A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Orchid Chemicals And Pharmaceuticals Ltd. |
Oxazole derivatives as antibacterial agents
|
JP2007503426A
(ja)
*
|
2003-08-25 |
2007-02-22 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
新規な抗微生物性アリールオキサゾリジノン化合物
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
US7304050B2
(en)
*
|
2003-09-16 |
2007-12-04 |
Pfizer Inc. |
Antibacterial agents
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
WO2005051933A1
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
WO2005113520A1
(en)
*
|
2004-05-20 |
2005-12-01 |
Pharmacia & Upjohn Company Llc |
Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
|
WO2006004922A1
(en)
*
|
2004-06-29 |
2006-01-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form iv of linezolid
|
EP1802613A1
(de)
*
|
2004-10-11 |
2007-07-04 |
Ranbaxy Laboratories Limited |
Substituierte oxazolidinonderivate
|
EP1685841A1
(de)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
WO2006091731A2
(en)
*
|
2005-02-24 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Processes for the preparation of linezolid intermediate
|
EP1874782A1
(de)
|
2005-04-15 |
2008-01-09 |
Ranbaxy Laboratories Limited |
Oxazolidinon-derivate als antimikrobielle mittel
|
JP2008544979A
(ja)
|
2005-06-29 |
2008-12-11 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
抗菌剤としてのホモモルホリンオキサゾリジノン
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
DK1934208T3
(da)
|
2005-10-04 |
2011-07-18 |
Bayer Schering Pharma Ag |
Ny polymorf form af 5-chlor-N-({(5S)-2-0x0-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
WO2008010070A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Orchid Research Laboratories Limited |
Novel oxazolidinone derivatives
|
US7593630B2
(en)
|
2006-07-24 |
2009-09-22 |
Foxconn Technology Co., Ltd. |
Built-in multidriver device for a camera zoom lens
|
US20100298384A1
(en)
*
|
2006-12-04 |
2010-11-25 |
Mohamed Takhi |
Novel oxazolidinone compounds as antiinfective agents
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
WO2009032294A2
(en)
*
|
2007-09-06 |
2009-03-12 |
Teva Pharmaceutical Industries Ltd. |
Processes for the preparation of a linezolid intermediate, linezolid hydroxide
|
WO2009120789A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Global Alliance For Tb Drug Development |
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
|
EP2138178A1
(de)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninone zur Behandlung der chronisch obstruktiven Lungenerkrankung (COPD) und/oder Asthma
|
EP2140866A1
(de)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinone zur Behandlung von Entzündungserkrankungen des Magen-Darm-Trakts
|
EP2757104B1
(de)
|
2008-10-10 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
In der synthese von oxazolidinonen verwendete verbindungen
|
PT2364975E
(pt)
*
|
2008-10-27 |
2013-09-09 |
Mitsubishi Tanabe Pharma Corp |
Novo derivado de amida e sua utilização como medicamento
|
JP5662940B2
(ja)
*
|
2008-11-20 |
2015-02-04 |
パナセア バイオテック リミテッド |
新規な抗微生物薬
|
ES2734724T3
(es)
|
2009-02-03 |
2019-12-11 |
Merck Sharp & Dohme |
Forma cristalina de dihidrogenofosfato de (R)-3-(4-(2-(2-metiltetrazol-5-il)piridin-5-il)-3-fluorofenil)-5-hidroximetiloxazolidin-2-ona
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
CN103360379B
(zh)
*
|
2012-03-31 |
2017-05-24 |
南京圣和药业股份有限公司 |
噁唑烷酮化合物
|
WO2017156519A1
(en)
|
2016-03-11 |
2017-09-14 |
The Board Of Trustees Of The University Of Illinois |
Small-molecules active against gram-negative bacteria
|
WO2018237140A1
(en)
|
2017-06-23 |
2018-12-27 |
The Board Of Trustees Of The University Of Illinois |
TOPOISOMERASE INHIBITORS HAVING ANTIBACTERIAL ACTIVITY AND ANTI-CANCER ACTIVITY
|
KR20210038632A
(ko)
|
2018-07-25 |
2021-04-07 |
카딜라 핼쓰캐어 리미티드 |
포유류 감염 치료를 위한 신규 화합물
|
CN110372624A
(zh)
*
|
2019-08-13 |
2019-10-25 |
北京海美桐医药科技有限公司 |
一种噁唑烷酮类化合物、其制备方法及应用
|
WO2021184339A1
(en)
*
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|